publication venue for
- Future Trends in Antimicrobial Chemotherapy: Expert Opinion on the 43rdICAAC 2004
- IN-VITRO SUSCEPTIBILITY OF MULTIPLY RESISTANT STRAINS OF CORYNEBACTERIUM-JEIKEIUM 1993
- PROPHYLAXIS IN LARGE-BOWEL SURGERY - CEFTRIAXONE PLUS ORNIDAZOLE VERSUS CEFORANIDE PLUS ORNIDAZOLE, A PRELIMINARY-REPORT 1993
- SUSCEPTIBILITY OF CLINICAL ISOLATES OF HELICOBACTER-PYLORI TO ORAL ANTIMICROBIAL AGENTS 1993
- Short-Course Therapy of Gemifloxacin Effective Against Pneumococcal Pneumonia in Mice. 18:634-640. 2006
- Cutaneous Adverse Events and Gemifloxacin: Observations from the Clinical Trial Program. 18:447-447. 2006
- Adverse Cutaneous Reactions and Drugs: A Focus on Antimicrobials. 18:127-139. 2006
- Cutaneous Adverse Events and Gemifloxacin: Observations from the Clinical Trial Program. 18:3-11. 2006
- Erratum: Cutaneous adverse events and gemifloxacin: Observations from the clinical trial program (Journal of Chemotherapy (2006) 18,1)). 18:447. 2006
- An updated safety profile of moxifloxacin.. 14 Suppl 2:29-34. 2002
- Un Aggiornato Profilo di Sicurezza della Moxifloxacina. 14:13-19. 2002
- Efficacy of Gemifloxacin in Acute Exacerbations of Chronic Bronchitis: a Randomised, Double-Blind Comparison with Trovafloxacin. 13:288-298. 2001
- Gemifloxacin versus Amoxicillin/Clavulanate in the Treatment of Acute Exacerbations of Chronic Bronchitis. 12:314-325. 2000